We have a highly distinguished and multidisciplinary Founding Board of Directors composed of leaders within the blood disorders arena.
Andra H. James, MD, MPH
Professor of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine at Duke University Medical Center, and consulting professor of Medicine, Division of Hematology. Founder of Duke University's Women's Hemostasis and Thrombosis Clinic. An Ob/Gyn and high-risk pregnancy expert, Dr. James is an internationally renowned leader in advancing the optimal treatment and management of women with blood disorders and is the recipient of the CDC Blood Disorders in Public Health Outstanding Leadership Award 2012; and the HTRS Lifetime Achievement Award 2017.
Barbara A. Konkle, MD
Associate Chief Scientific Officer at the Bloodworks North West. Dr. Konkle is also a Professor of Medicine, Division of Hematology, at the University of Washington. Dr. Konkle has long been committed to improving the care of women with bleeding and clotting disorders through research, clinical care and leadership in national organizations.
Roshni Kulkarni, MD
Professor (emeritus) and Director of Pediatric Hematology/Oncology at Michigan State University. Dr. Kulkarni was the Director of CDC's Division of Blood Disorders and Distinguished Hematology Consultant for CDC. She serves on Boards of national and international organizations, including ASPHO, ATHN, and ISTH, and has received the US FDA Distinguished Service Award.
Leslie J. Graham, MSHA
President and CEO, Primary Care Coalition, Silver Spring, MD. Ms. Graham's expertise includes improving healthcare quality and access while managing costs, especially for the underserved and women.
Janice Bacon, MD
Practicing Ob/Gyn at the Women’s Health & Diagnostic Center at Lexington Medical Center, West Columbia, South Carolina. Dr. Bacon is currently the president-elect of the South Atlantic Association of Obstetricians and Gynecologists. She was also the past president of the North American Society of Pediatric Gynecologists (NASPAG). Dr. Bacon’s professional interests include pediatric and adolescent gynecology and contraceptive management.
Kenneth Mann, PhD
Dr. Kenneth Mann, Emeritus Professor of Biochemistry and of Medicine at the University of Vermont, has a long distinguished career characterized by quality science, well-managed large-scale interdisciplinary research enterprises and excellence in service to medical, lay and professional organizations. Among the many awards Dr. Mann has received, his latest award is the Lifetime Achievement Award from the Hemostasis and Thrombosis Research Society - HTRS.
Michael Recht, MD, PhD
Medical Director of the Oregon Hemophilia Treatment Center, and the regional director for the federally funded Hemophilia Treatment Centers in the states of Oregon, Washington, Idaho, and Alaska. Dr. Recht is a member of the Division of Pediatric Hematology/Oncology at Oregon Health and Science University and directs the pediatric hematology consult service. Current focal areas of his work include the treatment of children and adolescents affected by non-malignant blood conditions, particularly bleeding and clotting issues.
Ravindra Sarode, MD
Chief of Pathology and Professor of Pathology, as well as the Medical Director of Clinical Laboratory Services and the Medical Director of the Division of Transfusion Medicine and Hemostasis at University of Texas Southwestern Medical Center. Current focal areas of his work include apheresis, platelet dysfunction, hypercoagulability, and thrombotic thrombocytopenic purpura. Endowed Title: John H. Childers, MD, Professorship in Pathology
Russell E. Ware, MD, PhD
Director, Division of Hematology at Cincinnati Children's. Dr. Ware is also the Institute Co-Director of the Cancer and Blood Diseases Institute and the Associate Director of the Global Health Center. Dr. Ware has been involved with a wide variety of clinical and translational hematology research projects for 25 years, however, his primary interests have focused on sickle cell disease. He currently runs an NIH-funded laboratory effort investigating genetic modifiers of sickle cell disease.